Clindamycin Phosphate in 0.9% Sodium Chloride Injection recall: CGMP Deviations
Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg/mL), 50 mL Single-Dose GALAXY Container, Rx only, Sterile…
Why was Clindamycin Phosphate in 0.9% Sodium Chloride Injection recalled?
CGMP Deviations
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot # NC193689, Exp Date: 10/16/2027.
- Product
- Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg/mL), 50 mL Single-Dose GALAXY Container, Rx only, Sterile…
- Recalling firm
- Baxter Healthcare Corporation
- Quantity
- N/A
- Distribution
- US Nationwide; Puerto Rico; and Chile.
- Recall date
- September 9, 2026
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)